Identifying the Genes Impacted by Cell Proliferation in Proteomics and Transcriptomics Studies

Overview

Journal PLoS Comput Biol

Specialty Biology

Date 2022 Oct 6

PMID 36201535

Authors

Marie Locard-Paulet

Oana Palasca

Lars Juhl Jensen

Affiliations

Soon will be listed here.

Abstract

Hypothesis-free high-throughput profiling allows relative quantification of thousands of proteins or transcripts across samples and thereby identification of differentially expressed genes. It is used in many biological contexts to characterize differences between cell lines and tissues, identify drug mode of action or drivers of drug resistance, among others. Changes in gene expression can also be due to confounding factors that were not accounted for in the experimental plan, such as change in cell proliferation. We combined the analysis of 1,076 and 1,040 cell lines in five proteomics and three transcriptomics data sets to identify 157 genes that correlate with cell proliferation rates. These include actors in DNA replication and mitosis, and genes periodically expressed during the cell cycle. This signature of cell proliferation is a valuable resource when analyzing high-throughput data showing changes in proliferation across conditions. We show how to use this resource to help in interpretation of in vitro drug screens and tumor samples. It informs on differences of cell proliferation rates between conditions where such information is not directly available. The signature genes also highlight which hits in a screen may be due to proliferation changes; this can either contribute to biological interpretation or help focus on experiment-specific regulation events otherwise buried in the statistical analysis.

Citing Articles

BRAF-PROTAC versus inhibitors in melanoma cells: Deep transcriptomic characterisation.

Alhassan S, Abd Elmageed Z, Errami Y, Wang G, Abi-Rached J, Kandil E Clin Transl Med. 2025; 15(3):e70251.

PMID: 40045459 PMC: 11882472. DOI: 10.1002/ctm2.70251.

Patient-derived response estimates from zero-passage organoids of luminal breast cancer.

Przanowska R, Labban N, Przanowski P, Hawes R, Atkins K, Showalter S Breast Cancer Res. 2024; 26(1):192.

PMID: 39741344 PMC: 11687200. DOI: 10.1186/s13058-024-01931-5.

Brain-body mitochondrial distribution patterns lack coherence and point to tissue-specific and individualized regulatory mechanisms.

Devine J, Monzel A, Shire D, Rosenberg A, Junker A, Cohen A bioRxiv. 2024; .

PMID: 39345381 PMC: 11430016. DOI: 10.1101/2024.09.20.614152.

Bhlhe40 Regulates Proliferation and Angiogenesis in Mouse Embryoid Bodies under Hypoxia.

Acosta-Iborra B, Gil-Acero A, Sanz-Gomez M, Berrouayel Y, Puente-Santamaria L, Alieva M Int J Mol Sci. 2024; 25(14).

PMID: 39062912 PMC: 11277088. DOI: 10.3390/ijms25147669.

Identification of unique cell type responses in pancreatic islets to stress.

Maestas M, Ishahak M, Augsornworawat P, Veronese-Paniagua D, Maxwell K, Velazco-Cruz L Nat Commun. 2024; 15(1):5567.

PMID: 38956087 PMC: 11220140. DOI: 10.1038/s41467-024-49724-w.

References

Monsivais D, Vasquez Y, Chen F, Zhang Y, Chandrashekar D, Faver J . Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers. Oncogene. 2021; 40(11):2081-2095. PMC: 7981264. DOI: 10.1038/s41388-021-01681-0. View

Pfister T, Reinhold W, Agama K, Gupta S, Khin S, Kinders R . Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol Cancer Ther. 2009; 8(7):1878-84. PMC: 2728499. DOI: 10.1158/1535-7163.MCT-09-0016. View

Mimori K, Sadanaga N, Yoshikawa Y, Ishikawa K, Hashimoto M, Tanaka F . Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment. Br J Cancer. 2006; 94(12):1894-7. PMC: 2361361. DOI: 10.1038/sj.bjc.6603182. View

Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M . Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002; 18 Suppl 1:S96-104. DOI: 10.1093/bioinformatics/18.suppl_1.s96. View

Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla R, Young R . A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell. 2004; 16(3):399-411. DOI: 10.1016/j.molcel.2004.09.037. View

Davis S, Meltzer P . GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007; 23(14):1846-7. DOI: 10.1093/bioinformatics/btm254. View

Frejno M, Meng C, Ruprecht B, Oellerich T, Scheich S, Kleigrewe K . Proteome activity landscapes of tumor cell lines determine drug responses. Nat Commun. 2020; 11(1):3639. PMC: 7371697. DOI: 10.1038/s41467-020-17336-9. View

Wang B, Wang W, Zhu Z, Zhang X, Tang F, Wang D . Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma. Clin Neurol Neurosurg. 2017; 154:28-33. DOI: 10.1016/j.clineuro.2017.01.005. View

Patro R, Duggal G, Love M, Irizarry R, Kingsford C . Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017; 14(4):417-419. PMC: 5600148. DOI: 10.1038/nmeth.4197. View

10.

Ghandi M, Huang F, Jane-Valbuena J, Kryukov G, Lo C, McDonald 3rd E . Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019; 569(7757):503-508. PMC: 6697103. DOI: 10.1038/s41586-019-1186-3. View

11.

Rouzier R, Rajan R, Wagner P, Hess K, Gold D, Stec J . Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A. 2005; 102(23):8315-20. PMC: 1149405. DOI: 10.1073/pnas.0408974102. View

12.

Hammond C, Bao H, Hendriks I, Carraro M, Garcia-Nieto A, Liu Y . DNAJC9 integrates heat shock molecular chaperones into the histone chaperone network. Mol Cell. 2021; 81(12):2533-2548.e9. PMC: 8221569. DOI: 10.1016/j.molcel.2021.03.041. View

13.

Durinck S, Spellman P, Birney E, Huber W . Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc. 2009; 4(8):1184-91. PMC: 3159387. DOI: 10.1038/nprot.2009.97. View

14.

Wagner P, Wang B, Clark E, Lee H, Rouzier R, Pusztai L . Microtubule Associated Protein (MAP)-Tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo. Cell Cycle. 2005; 4(9):1149-52. DOI: 10.4161/cc.4.9.2038. View

15.

Ross D, Scherf U, Eisen M, Perou C, Rees C, Spellman P . Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000; 24(3):227-35. DOI: 10.1038/73432. View

16.

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S . The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012; 483(7391):603-7. PMC: 3320027. DOI: 10.1038/nature11003. View

17.

Santos A, Wernersson R, Jensen L . Cyclebase 3.0: a multi-organism database on cell-cycle regulation and phenotypes. Nucleic Acids Res. 2014; 43(Database issue):D1140-4. PMC: 4383920. DOI: 10.1093/nar/gku1092. View

18.

Guo T, Luna A, Rajapakse V, Koh C, Wu Z, Liu W . Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines. iScience. 2019; 21:664-680. PMC: 6889472. DOI: 10.1016/j.isci.2019.10.059. View

19.

Doncheva N, Morris J, Gorodkin J, Jensen L . Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data. J Proteome Res. 2018; 18(2):623-632. PMC: 6800166. DOI: 10.1021/acs.jproteome.8b00702. View

20.

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View